Valuation: Cellnovo

Market Cap 2.44M 2.17M 2.02M 1.84M 3.47M 235M 3.49M 24.46M 9.52M 120M 9.14M 8.95M 385M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 11.11M 10.35M 9.42M 17.74M 1.2B 17.88M 125M 48.68M 612M 46.77M 45.76M 1.97B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+1.48%+3.13%+1.51%+64.45% 3,843B
+0.34%+1.02%+9.44%+1,097.98% 454B
+0.13%+7.45%-50.21%+31.50% 431B
+0.87%+3.74%+96.32%+243.58% 330B
+0.97%+5.18%+122.64%+559.86% 277B
+0.61%+0.55%-19.60%+51.50% 239B
+1.27%+3.52%-25.42%+24.35% 139B
+1.76%+4.42%+114.63%+217.36% 133B
-0.29%+2.87%+82.07%+208.71% 99.54B
Average +0.26%+2.91%+36.82%+277.70% 594.5B
Weighted average by Cap. -0.20%+3.06%+11.67%+178.31%

Financials

2018 2019 *
Net sales 3.32M 2.96M 2.76M 2.51M 4.73M 320M 4.77M 33.36M 12.98M 163M 12.47M 12.2M 525M -
Net income -15.94M -14.22M -13.25M -12.06M -22.7M -1.54B -22.87M -160M -62.28M -783M -59.84M -58.54M -2.52B -
Net Debt 10.02M 8.94M 8.33M 7.58M 14.28M 965M 14.38M 101M 39.16M 493M 37.62M 36.81M 1.58B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock